Sage Journals: Discover world-class research

Open access

Case report

First published 2015-3

Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues

Umar Y Raja, Alison E Eastaugh, Mohammed S Younas [...]

JRSM Cardiovascular Disease

Free access

Research article

First published 2015-1-1

Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging

Babak Behnam Azad, Vanessa Rota, Lihai Yu [...]

Molecular Imaging

Retricted access

Review article

First published 2008-11

Liraglutide,a once-daily human GLP-1 analogue

Michael A Nauck

The British Journal of Diabetes & Vascular Disease

Open access

Research article

First published 2020

The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer’s Disease

Mark Maskery, Elizabeth Mary Goulding, Simon Gengler [...]

American Journal of Alzheimer's Disease & Other Dementias®

Retricted access

Research article

First published 2014-4

Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells

Guanglei Chang, Dongying Zhang, Jian Liu [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2010-7

Understanding GLP-1 Analogs and Enhancing Patient Success

Davida F. Kruger, Bruce Bode, Geralyn R. Spollett

The Science of Diabetes Self-Management and Care

Retricted access

Research article

First published 2013-1

Type 1 Diabetes Treatment beyond Insulin: Role of GLP-1 Analogs

Lindsay B. Harrison, Pablo F. Mora, Gregory O. Clark [...]

Journal of Investigative Medicine

Retricted access

Review article

First published 2026-1

Assessment of the Potential of GLP-1 Analogs in the Treatment of Addictions: A Literature Review

Isabel Noemi Torres, Maria Jimena Barroso Alverde

Substance Use & Addiction Journal

Open access

Review article

First published 2014-9

The effects of GLP-1 analogues,DPP-4 inhibitors and SGLT2 inhibitors on the renal system

Guntram Schernthaner, Carl Erik Mogensen, Gerit-Holger Schernthaner

Diabetes & Vascular Disease Research

Open access

Research article

First published 2018-06

The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs

Helena W. Rodbard

Diabetes Technology & Therapeutics

Search results